Beyond Air (XAIR) Cash from Operations Growth (3y) (2019 - 2026)
Powered by 
Analysis
Beyond Air (XAIR) Cash from Operations Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 9.30% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | 33.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.94% |
| Mar 31, 2026 | 16.33% |
| Dec 31, 2025 | 20.85% |
| Sep 30, 2025 | 14.49% |
| Jun 30, 2025 | 12.86% |
| Mar 31, 2025 | 4.15% |
| Dec 31, 2024 | -47.78% |
| Sep 30, 2024 | -67.15% |
| Jun 30, 2024 | -37.48% |
| Mar 31, 2024 | -24.42% |
| Dec 31, 2023 | -37.94% |
| Sep 30, 2023 | -62.77% |
| Jun 30, 2023 | -46.23% |
| Mar 31, 2023 | -20.20% |
| Dec 31, 2022 | -21.39% |
| Sep 30, 2022 | -37.78% |
| Jun 30, 2022 | -32.96% |
| Mar 31, 2022 | -46.03% |
| Dec 31, 2021 | 80.07% |
| Sep 30, 2021 | 68.37% |